Jan 22, 2025
Acute Myeloid Leukemia (AML) represents a significant public health concern globally, with its prevalence and incidence on the rise. According to the American Cancer Society’s estimates for 2025, approximately 22K people in the United States are expected to be diagnosed with AML, with most cases occurring in adults...
Read More...
Oct 02, 2024
Rheumatoid arthritis is a chronic autoimmune disease that wreaks havoc on the joints, causing progressive and destructive polyarthritis. According to the World Health Organization, approximately 18 million people globally live with this condition, with about 1.5 million cases reported in the U.S. Characterized by r...
Read More...
Aug 18, 2024
"Research is the only hope for families affected by Duchenne muscular dystrophy, and every step forward is a step closer to a cure." Duchenne Muscular Dystrophy (DMD) is a severe form of muscular dystrophy characterized by progressive muscle degeneration and weakness. It is a rare disorder, but it is one of th...
Read More...
Mar 18, 2016
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. Del...
Read More...
DAWNZERA’s EU Approval Strengthens the Hereditary Angioedema Treatment Landscape
Jan 30, 2026
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Nov 04, 2025
Wireless Brain Sensors: Revolutionizing Neuroscience and Healthcare
Oct 28, 2025
The Dynamic Landscape of Myelofibrosis Treatment: A 2024 Perspective
Jun 10, 2024
Newsletter/Whitepaper